THE ROLE OF EARLY-STAGE DETECTION IN THE PROGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

Abstract

This study investigates the role of early-stage detection in the prognosis of Head and Neck Squamous Cell Carcinoma (HNSCC), focusing on how timely diagnosis influences survival rates, recurrence, and treatment outcomes. A retrospective analysis of patient data reveals a significant difference in survival between early and late-stage diagnoses, with patients diagnosed at Stage I and II demonstrating higher five-year survival rates and reduced recurrence rates compared to those diagnosed at advanced stages (III and IV). Advanced diagnostic techniques, such as high-definition endoscopy, liquid biopsy, and HPV DNA testing, show high sensitivity and accuracy, with liquid biopsy emerging as a particularly promising method for early detection. Patients diagnosed early were more likely to receive less invasive treatments, which resulted in better functional outcomes and fewer long-term complications. This research indicates that patients who smoke experience reduced survival times together with higher recurrence rates during HNSCC diagnosis.  Early diagnosis of diseases at their first stage allows physicians to prescribe less intense therapeutic treatments that decrease both expenses and death rates among patients per this study.  Early detection programs face challenging barriers to reach a wide audience and poor knowledge about screenings in spite of improved diagnostic equipment.  The obtained evidence supports ongoing innovation in diagnostic tools for medical practice and education about early detection and fair healthcare resource distribution.  The results create a basis for both legislative adjustments and strategic measures that would lead to enhanced early detection practices and increased favorable results for patients with HNSCC.